12:00 AM
Aug 09, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Afluria regulatory update

FDA updated the label for CSL's Afluria to warn that the trivalent inactivated seasonal influenza vaccine has been associated with an increased incidence of fever and febrile seizure in Australian children, mainly under the...

Read the full 149 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >